Zimmer Biomet - ZBH Total Company Value-to-Revenue Ratio

Zimmer Biomet Holdings, Inc. (ZBH) - corporate logo

Zimmer Biomet Holdings (ZBH) dominates the joint implant segment, leveraging the consistent demand of an aging population and a stable cash flow. The EV/Sales trend illustrates current price corridors, where the 3070.79 level captures the current state. Cost optimization via contract manufacturing accelerates the launch of new products, while expansion into robotic surgery and ambulatory centers extends its market influence.

Zimmer Biomet Corp (ZBH) EV/Sales Multiple: for the period 11/23/2025 - 11/20/2026

Financial and market metric breakdowns for Zimmer Biomet Holdings, Inc. (ZBH)

- share price and consensus valuation forecast:
- cash and cash flow indicators:
Fundamental company valuation:ZBH, Zimmer Biomet Holdings
Flagship merchandise of Zimmer Biomet

EV/Sales (co) measures the total enterprise value of the business, including debt, relative to annual revenue, thereby excluding the impact of credit load on the valuation. For Zimmer Biomet Holdings (ZBH), this filter is critical, as revenue scalability is driven by installed equipment and consistent demand for proprietary implants. Analyzing the enterprise value-to-revenue ratio on GURU.Markets allows investors to promptly identify asset overvaluation or determine a safe entry point.

Competitor analysis

BSX (Boston Scientific) - Company Value to Revenue Ratio|EW: EV/Sales Multiple|RMD - Total Company Value-to-Revenue Ratio|PODD (Insulet Inc.) - EV/Sales Multiple|Company Value to Revenue CooperVision (COO)|EV/Sales Multiple ALGN|Company Value to Revenue Globus Medical, Inc. GMED|EV/Sales Multiple TMDX (transmedics.com)|EV/Sales Multiple Alphatec Holdings ATEC|AORT - Enterprise Value-to-Revenue Ratio|ENOV: Enterprise Value-to-Revenue Ratio|IART (Integra LifeSciences) - Company Value to Revenue|Establishment Labs - Business Value to Revenue|BBNX (iLet Bionic Pancreas) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple IRADIMED Corp IRMD|Enterprise Value-to-Revenue Ratio Embecta Corp (EMBC)|Tandem Diabetes Care (TNDM) - Enterprise Value-to-Sales Ratio|Axogen Surgical - Company Value to Revenue|EV/Sales Multiple SI-BONE, Inc. SIBN|Orthofix Medical - EV/Sales Multiple|Enterprise Value to Sales Volume BVS|OrthoPediatrics (KIDS) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume TMCI (Treace Corp)|Enterprise Value-to-Revenue Ratio blade.com|Company Value to Revenue Carlsmed Inc (CARL)|EV/Sales Multiple RXST|CLPT - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio Stereotaxis, Inc. STXS|STIM: Company Value to Revenue Ratio|SGHT: Company Value to Revenue|Orchestra BioMed Inc. - Enterprise Value-to-Revenue Coefficient|ANIK: EV/Sales Multiple|NSPR - Total Company Value-to-Revenue Ratio|ZJYL (Jin Medical) - EV/Sales Multiple|Vivani Medical (VANI) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple XTNT|EV/Sales Multiple n1mtc.com (NMTC)|Modular Medical Inc - Company Value to Revenue|Myomo, Inc (MYO) - Enterprise Value-to-Revenue Multiple|COCH: Company Value to Revenue|Total Company Value-to-Revenue Ratio Vivos Therapeutics VVOS|enVVeno Medical Corp. (NVNO) - Enterprise Value-to-Revenue Ratio|Sintx Technologies - Business Value to Revenue|Enterprise Value-to-Revenue Ratio Tenon Medical Inc.|LFWD: Business Value to Revenue|EV/Sales Multiple AMIX|Enterprise Value-to-Revenue Coefficient IVF|Enterprise Value-to-Revenue Ratio Bone Biologics BBLG|Total Company Value-to-Revenue Ratio axonics.com (AXNX)|BIOL - Enterprise Value-to-Revenue Ratio|Dynatronics (DYNT) - Company Value to Revenue|Paragon 28, Inc. (FNA) - Enterprise Value-to-Revenue Ratio|INVO - Total Company Value-to-Revenue Ratio